NATCO Pharma Limited (NSE:NATCOPHARM)
816.65
+10.10 (1.25%)
Oct 3, 2025, 10:30 AM IST
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.